Ronn Inc. Executes And Launches Phase One Agreement in Saudi Arabia, Accelerating Hydrogen Technology and Strategic Investment
SCOTTSDALE, AZ / ACCESS Newswire / April 9, 2025 / Ronn Inc. (OTC PINK:RONN), A global innovator in hydrogen mobility and clean energy infrastructure, announced today that it has entered into a Strategic Commercial Market Access Agreement with a respected international intermediary group specializing in Saudia Arabia with early-stage relationship development between high-growth technology firms and sovereign infrastructure partners.
This agreement represents Phase One of a broader framework intended to position Ronn Inc. for a long-term financial and technology partnership across both the United States and the Kingdom of Saudi Arabia. 'It will establish our manufacturing and production in Saudi Arabia as well as the US where the collaboration with Saudi Arabia is a powerful collaboration at this time,' said Ronn Ford, CEO of Ronn Inc. The discussions currently underway are aimed at forming a 50/50 regional joint venture, which would establish a significant operating presence for Ronn Inc. within the Kingdom.
'Our team is proud to be building what we believe will become a transformational long-term alliance,' said Ronn Ford, CEO of Ronn Inc. 'Saudi Arabia continues to demonstrate visionary leadership in innovation, infrastructure, and energy transformation. We are honored to be invited into this dialogue and to contribute to the country's dynamic Vision 2030 roadmap.'
The proposed joint venture in The Kingdom Of Saudi Arabia is expected to focus on localized manufacturing and regional deployment of Ronn Inc.'s hydrogen technologies, including hydrogen-powered supercars, commercial mobility platforms, hydrogen trucks, and modular fueling infrastructure. These initiatives are fully aligned with the Kingdom's Vision 2030 strategy and its multi-sector commitment to hydrogen as a central pillar of its future energy landscape.
The announcement follows recent news of Saudi Arabia's intent to commit over one trillion dollars in U.S. strategic investments, reinforcing the deepening collaboration between both nations in advanced technologies and industrial innovation.
Phase 1: Current planning includes the establishment of a regional headquarters in the Kingdom, in collaboration with a group of strategic partners with proven success in rail technology, real estate, transportation, and public-private mega infrastructure.
Further details on phase 2 and phase 3 in Saudi Arabia will be disclosed as the joint venture structure and operating scope are finalized.
Forward-Looking Statements
This press release contains forward-looking statements subject to inherent risks and uncertainties. Actual results may vary materially due to numerous factors beyond the company's control. RONN Inc. undertakes no obligation to revise or update these statements unless legally required publicly.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
32 minutes ago
- Indianapolis Star
Tecogen to Participate in Roth Conference in London
NORTH BILLERICA, MA / ACCESS Newswire Tecogen Inc. (NYSE American:TGEN) a leading manufacturer of clean energy products, today announced that Abinand Rangesh, Chief Executive Officer, will participate in the 15 th Annual Roth Conference hosted in London, England on June 24 th to 26 th, 2025. Management will be available for one-on-one meetings during the conference. Attending investors interested in meeting Dr. Rangesh should contact their Roth representative or email investorrelations@ About Tecogen Tecogen designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit or contact us for a free Site Assessment. Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as 'believe,' 'expect,' 'anticipate,' 'intend,' 'plan,' 'estimate,' 'project,' 'target,' 'potential,' 'will,' 'should,' 'seek,' 'could,' 'likely,' 'may,' 'pro forma,' 'anticipate,' 'continue,' or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements. In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Form 8-K, under 'Risk Factors,' among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth. Tecogen Media & Investor Relations Contact Information: Abinand Rangesh, CEO P: 781-466-6487 E: SOURCE: Tecogen, Inc.
Yahoo
4 hours ago
- Yahoo
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) ('AIM' or the 'Company') today announced a reverse stock split ('Reverse Stock Split') of its shares at a ratio of 1-for-100. The Reverse Stock Split will take effect at market open tomorrow, June 12, 2025. The Company's ticker symbol on the OTC Pink will be AIMID for 20 trading days, including the effective date. One of the primary goals of the Reverse Stock Split is to increase the per-share market price of the Company's common stock to enable the Company to regain compliance with the NYSE American's Listing Qualifications. At a Special Meeting of Stockholders held on April 30, 2025, the Company's stockholders approved a series of alternate amendments to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's outstanding common stock at a ratio in the range of up to 1-for-100, with such ratio to be determined by the Company's Board of Directors. Stockholders will be given cash in lieu of any fractional shares on a post-split basis. Following the Reverse Stock Split, the new CUSIP number of the common stock will be 00901B303, with the par value per share of common stock remaining at $0.001. About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company's lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit and connect with the Company on X, LinkedIn, and Facebook. Cautionary Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the 'PSLRA'). Words such as 'may,' 'will,' 'expect,' 'plan,' 'anticipate,' 'continue,' 'believe,' 'potential,' 'upcoming' and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date do not guarantee that Ampligen will be approved as a therapy in any indication. The Company urges investors to consider specifically the various risk factors identified in its most recent Form 10-K, and any risk factors or cautionary statements included in any subsequent Form 10-Q or Form 8-K, filed with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908.824.0775 AIM@
Yahoo
4 hours ago
- Yahoo
01 Communique Engages Oak Hill
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - 01 Communique Laboratory Inc. (TSXV: ONE) (OTC Pink: OONEF) (the "Company"), one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era, is pleased to announce that it has retained the services of Oak Hill Financial Inc. ("Oak Hill") to provide, among other things, investor relations, business and capital markets advisory services to the Company (the "Services"). Oak Hill is a Toronto-based investor relations and capital markets advisory firm that has been engaged to, among other things, heighten market and brand awareness for the Company as well as to broaden the awareness of the Company within the investment community via email and phone campaigns. The agreement with Oak Hill is effective as of June 10, 2025 and has an initial period of two months. The agreement is subject to TSX Venture Exchange approval. Oak Hill has agreed to comply with all applicable securities laws and policies of the TSX Venture Exchange in providing its Services. In connection with the Services, Oak Hill will be paid a monthly fee of $12,000, plus applicable taxes. Neither Oak Hill nor its principals have any interest, directly or indirectly, in the Corporation or its securities, or any right or intent to acquire such an interest. About 01 Communique Established in 1992, 01 Communique (TSXV: ONE) (OTC Pink: OONEF) has always been at the forefront of technology. The Company's cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP™ product line. IronCAP™'s technologies are patent-protected in the U.S.A. by its patents #11,271,715 and #11,669,833. The Company's remote access business unit provides its customers with a suite of secure remote access services and products under its I'm InTouch and I'm OnCall product offerings. The remote access offerings are protected in the U.S.A. by its patents #6,928,479 / #6,938,076 / #8,234,701; in Canada by its patents #2,309,398 / #2,524,039 and in Japan by its patent #4,875,094. For more information, visit the Company's web site at and Neither TSX Venture Exchange ("TSX-V") nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. INVESTOR CONTACT:Brian StringerChief Financial Officer01 Communique(905) 795-2888 To view the source version of this press release, please visit Sign in to access your portfolio
